Bionano Genomics (BNGO)
(Delayed Data from NSDQ)
$1.76 USD
+0.08 (4.76%)
Updated Sep 24, 2025 03:59 PM ET
After-Market: $1.77 +0.01 (0.57%) 5:24 PM ET
2-Buy of 5 2
C Value A Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
BNGO 1.76 +0.08(4.76%)
Will BNGO be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for BNGO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BNGO
Despite Fast-paced Momentum, Bionano Genomics (BNGO) Is Still a Bargain Stock
Bionano Genomics (BNGO) Is Attractively Priced Despite Fast-paced Momentum
BNGO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue Estimates
Other News for BNGO
BNGO makes New 52 Week Closing Low on September 24
BNGO makes New 52 Week Closing Low on September 22
NR7 appears for BNGO after 0.0% move
BNGO forms NR7 on September 18
Is BNGO primed for downward momentum? New 52 Week Closing Low shows up after sliding 0.56%